What happened
Ilyang Pharmaceutical updated a previously disclosed supply contract, now worth US$8.94M, about 5.15% of its recent annual revenue, running through Jun 2026.
For context, this single contract equals about 5.15% of the company's most recent annual revenue.
| Counterparty | Disclosed |
|---|---|
| Contract value | US$8.94M |
| vs. recent revenue | 5.15% |
| Through | Jun 2026 (from Jun 2025) |
| Filed | 2026-06-30, [Amended] Supply contract signed |
| Source | DART rcept 20260630800808 → open original filing |
Source: DART. Information only, not investment advice.